Creative Medical Technology
CELZ
14 hedge funds and large institutions have $253K invested in Creative Medical Technology in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
17% more funds holding
Funds holding: 12 → 14 (+2)
8% more capital invested
Capital invested by funds: $233K → $253K (+$19.2K)
2.25% more ownership
Funds ownership: 2.74% → 4.99% (+2.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$89.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$51.6K |
| 3 |
GRP
Global Retirement Partners
San Rafael,
California
|
+$23.4K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$15.4K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$14.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
-$14.1K |
| 2 |
AF
Allworth Financial
Folsom,
California
|
-$13.3K |
| 3 |
Jones Financial Companies
Des Peres,
Missouri
|
-$3.32K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$658 |
CELZ Hedge Fund Activity: Q4 2025 in Review
14 of the 8,264 institutional investors tracked by Wall St. Rank reported a position in Creative Medical Technology (CELZ) for Q4 2025, worth a combined $253K — up 8.2% from $233K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CELZ positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $89.3K. The largest seller was DRW Securities, cutting an estimated $14.1K.
- 14 institutional investors held Creative Medical Technology (CELZ) as of Q4 2025, up from 12 in Q3 2025.
- Funds reported $253K of Creative Medical Technology stock for Q4 2025, up 8.2% quarter-over-quarter.
- 5 funds opened new Creative Medical Technology positions in Q4 2025 and 3 closed out, a net change of +2 holders.
- The largest Creative Medical Technology buyer in Q4 2025 was Jane Street, an estimated $89.3K added.
- The largest Creative Medical Technology seller in Q4 2025 was DRW Securities, an estimated $14.1K sold.
Based on aggregated 13F filings for Q4 2025.